EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes

Guy S Taylor, Kieran Smith, Jadine Scragg, Timothy J McDonald, James A Shaw, Daniel J West, Lee D Roberts

Diabetologia · 2024

DOI: 10.1007/s00125-024-06153-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2024. Verfasst von Guy S Taylor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Human Nutrition & Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Metabolome, Exercise. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK, Diabetes Research and Wellness Foundation, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Our aim was to characterise the in-depth metabolic response to aerobic exercise and the impact of residual pancreatic beta cell function in type 1 diabetes. We also aimed to use the metabolome to distinguish individuals with type 1 diabetes with reduced maximal aerobic capacity in exercise defined by $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ˙ O 2peak .

Methods

Thirty participants with type 1 diabetes (≥3 years duration) and 30 control participants were recruited. Groups did not differ in age or sex. After quantification of peak stimulated C-peptide, participants were categorised into those with undetectable (200 pmol/l) residual beta cell function. Maximal aerobic capacity was assessed by $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ˙ O 2peak test and did not differ between control and type 1 diabetes groups. All participants completed 45 min of incline treadmill walking (60% $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ˙ O 2peak ) with venous blood taken prior to exercise, immediately post exercise and after 60 min recovery. Serum was analysed using targeted metabolomics. Metabolomic data were analysed by multivariate statistics to define the metabolic phenotype of exercise in type 1 diabetes. Receiver operating characteristic (ROC) curves were used to identify circulating metabolomic markers of maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ˙ O 2peak ) during exercise in health and type 1 diabetes.

Results

Maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ˙ O 2peak ) inversely correlated with HbA 1c in the type 1 diabetes group ( r 2 =0.17, p =0.024). Higher resting serum tricarboxylic acid cycle metabolites malic acid (fold change 1.4, p =0.001) and lactate (fold change 1.22, p =1.23×10 −5 ) differentiated people with type 1 diabetes. Higher serum acylcarnitines (AC) (AC C14:1, F value=12.25, p =0.001345; AC C12, F value=11.055, p =0.0018) were unique to the metabolic response to exercise in people with type 1 diabetes. C-peptide status differentially affected metabolic responses in serum ACs during exercise (AC C18:1, leverage 0.066; squared prediction error 3.07). The malic acid/pyruvate ratio in rested serum was diagnostic for maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ˙ O 2peak ) in people with type 1 diabetes (ROC curve AUC 0.867 [95% CI 0.716, 0.956]). Conclusions/interpretation The serum metabolome distinguishes high and low maximal aerobic capacity and has diagnostic potential for facilitating personalised medicine approaches to manage aerobic exercise and fitness in type 1 diabetes. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1MetabolomeExerciseHumansMaleFemaleAdultOxygen ConsumptionExercise TestMetabolomicsYoung AdultC-PeptideMiddle AgedInsulin-Secreting Cells

Stichwörter der Autor:innen

Aerobic exerciseDiagnosticMetabolismTargeted metabolomicsType 1 diabetes

Substanzen

C-Peptide

Autor:innen und Institutionen

  • Human Nutrition & Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • The Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
  • Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • University of Exeter Medical School, University of Exeter, Exeter, UK.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Human Nutrition & Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. Daniel.West@newcastle.ac.uk.

Förderung

  • Diabetes UK
  • Diabetes Research and Wellness Foundation
  • Biotechnology and Biological Sciences Research Council
  • Francis James Bell Endowment Fund
  • County Durham Community Foundation

Zitieren

APA

Taylor, G. S., Smith, K., Scragg, J., McDonald, T. J., Shaw, J. A., West, D. J., & Roberts, L. D. (2024). The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes. Diabetologia. https://doi.org/10.1007/s00125-024-06153-0

Vancouver

Taylor GS, Smith K, Scragg J, McDonald TJ, Shaw JA, West DJ, et al. The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes. Diabetologia. 2024. doi:10.1007/s00125-024-06153-0

BibTeX
@article{Taylor2024,
  author = {Taylor, Guy S and Smith, Kieran and Scragg, Jadine and McDonald, Timothy J and Shaw, James A and West, Daniel J and Roberts, Lee D},
  title = {The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes},
  journal = {Diabetologia},
  year = {2024},
  doi = {10.1007/s00125-024-06153-0}
}
Kostenlos starten →